Biogeography of the Oral Microbiome

Oral Microbiome Clinical Trial

Official title:

Biogeography of the Oral Microbiome Using Metatranscriptomic Analyses

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05672953
• Other study ID #: V243
• Status: Completed
• Start date: May 20, 2021
• Est. completion date: August 10, 2021

Study information

• Verified date: December 2022
• Source: Viome
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A cross-sectional study to metatranscriptomically analyze and compare the oral microbiome in different environmental niches within the oral cavity.

Description:

This study will collect samples from participants meeting the eligibility criteria over the span of 3 months. Samples will be collected from multiple locations within the oral cavity and metatranscriptomically analyzed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: August 10, 2021
• Est. primary completion date: August 10, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years old or older

Exclusion Criteria:

• Positive SARS-CoV-2 test result, if performed

• Antibiotic use in the previous 30 days

• Mouthwash use in the previous 6 months

Related Conditions & MeSH terms

• Oral Microbiome

Locations

Country	Name	City	State
United States	Viome Life Sciences	Bothell	Washington

Sponsors (1)

Lead Sponsor	Collaborator
Viome

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Species richness in multiple oral locations	Number of species present in different areas swabbed in the oral cavity.	3 months
Secondary	KO richness of multiple oral locations	KO richness of multiple areas swabbed in the oral cavity.	3 months